Pharmacokinetics : regulatory, industrial, academic perspectives

Author(s)

• Welling, Peter G.
• Tse, Francis L. S.

Bibliographic Information

Pharmacokinetics : regulatory, industrial, academic perspectives

edited by Peter G. Welling, Francis L.S. Tse

（Drugs and the pharmaceutical sciences, v. 67）

M. Dekker, c1995

2nd ed

Note

Includes bibliographical references and index

Description and Table of Contents

Description

Offering a unique, multidisciplinary approach, this state-of-the-art Second Edition details the rapidly changing role that clinical and non-clinical pharmacokinetics and drug metabolism play in the discovery and development of drug therapies-emphasizing often overlooked regulatory, scientific, and economic issues.

Table of Contents

Principles of the Good Laboratory Practice Regulations Applied to Pharmacokinetics, Dexter S. Goldman Methods to Assess Absorption in Drug Discovery, Karen Habucky Drug Delivery Systems: Effects of Pharmacokinetics on Design, Evaluation, and Production, C.T. Rhodes Peptide and Protein Drug Delivery, Vincent H.L. Lee Membrane Transport, Ernest M. Wright Blood-Brain Barrier Permeability: Pharmacological Implications with Special Emphasis on Peptides, William A. Banks and Abba J. Kastin Modeling of Relationships Between Pharmacokinetics and Pharmacodynamics, Meindert Danhof and Jaap W. Mandema Spatial Imaging of Radioactivity in Animal Tissues and Organs, A. Schweitzer Recent Developments in Drug Metabolism Methodology, Roger N. Hayes, William F. Pool, Michael W. Sinz, and Thomas F. Woolf Hepatic Microsome and Heterologous Expression Systems as In Vitro Models for Human Drug Metabolism, Thomas Kronbach Integration of Pharmacokinetics into Drug Discovery and Development: The Alternative Approaches, Peter G. Welling Pharmacokinetics in Drug Discovery and Development: Nonclinical Studies, Francis L.S. Tse Pharmacokinetics in Drug Discovery and Development: Clinical Studies, Horst F. Schran and James M. Jaffe Population Pharmacokinetics and Pharmacodynamics, Jaap W. Mandema Bioavailability and Bioequivalence of Oral Controlled-Release Products: A Regulatory Perspective, Henry J. Malinowski and James D. Henderson Statistical Considerations for Bioavailability Bioequivalence Studies, Lianng Yuh

by "Nielsen BookData"

Details

• NCID: BA24907122
• ISBN:
  • 0824793781
• LCCN: 94047123
• Country Code: us
• Title Language Code: eng
• Text Language Code: eng
• Place of Publication: New York
• Pages/Volumes: xi, 512p
• Classification:
  • LCC : RM301.5
  • DC20 : 615/.7
• Subject Headings:
  • LCSH : Pharmacokinetics
• Parent Bibliography ID:
  • BA03948165